11 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
International OCD Foundation Research Grant Program
IOCDF Research Grants Submissions will be accepted January 2, 2014 to February 28, 5pm EST, 2014.
The mission of the International OCD Foundation is to help individuals with obsessive compulsive disorder (OCD) and related disorders to live full and productive lives. Our aim is to increase access to effective treatment, end the stigma associated with mental health issues, and foster a community for those affected by OCD and the professionals who treat them.
About Our Research Grants
The IOCDF awards grants to investigators whose research focuses on the nature, causes and treatment of OCD and related disorders.
The IOCDF has a long history of funding projects for both junior and senior investigators. We are hoping that many junior investigators will apply this year as grant from us will help build their research programs and keep them interested in studying the field of OCD and related disorders.
Senior investigators may also ask for grant funding for projects that would provide pilot data for future larger scale federal grant applications.
If you have additional questions, please contact Barbara Rosemberg at firstname.lastname@example.org
FRAXA Research Foundation Grants & Postdoctoral Fellowships for Studies Aimed at Fragile X Treatment
FRAXA aims to accelerate research aimed at finding a specific treatment for fragile X syndrome. Our goal is to bring practical treatment into current medical practice as quickly as possible; therefore, preference will be given to research projects that have a clear practical application and the results of which will be shared in a timely fashion. The next application deadline is February 1, 2014.
FRAXA offers grants in two categories:
Program Grants are intended for only the most translationally relevant proposals; basic science proposals will be streamlined out without review.
Applicants with a more basic approach should consider the Postdoctoral Fellowship program, though these grants are still awarded with weight given to therapeutic potential.
-- $45,000 per year for 2 years (for salary, fringe benefits, & consumable costs)
-- Fixed amount and duration
-- Approximately 8 total fellowships available for 2014, depending on available funds
-- Applicants must be full time and have MD, PhD, or MD/PhD
-- Previous grad/postdoc FRAXA grantees are not eligible (previous PI is OK)
-- Limit of one application per lab group (current grantees are not eligible)
-- PIs must demonstrate adequate overall funding to pursue this project; no supplements will be given for supplies or animal care
-- Grants are non-transferable (only good for specified postdoc, PI, and institution)
FRAXA will offer a limited number of postdoctoral fellowships this year at a fixed rate of $45,000 per year. Successful applicants for these grants will likely be working in established labs with secure overall funding, which have funding for supplies and any required animal handling costs. If the applicant proposes to work with a particular fragile X model (KO mouse, drosophila, human neural stem cells, etc.) s/he should demonstrate that this model system has already been established in-house.
-- No limit to structure of grant (can fund PI, postdoc, grad student, technician, supplies, etc.) or timeframe (though all grants over one year still need yearly renewal)
-- Amount up to $100,000 per year (but please remember that applications are ranked based on relative value, so smaller requests have an advantage!)
-- Grants are given based on innovation and translational relevance: clinical trials are our highest priority, followed by preclinical research (i.e. rescue of animal models) and then translational research
-- Any application with low translational relevance will be streamlined out without review; FRAXA is not able to fund basic science applications in this program
FRAXA invites investigator-initiated research applications for innovative pilot studies aimed at developing and characterizing new therapeutic approaches for the treatment and ultimate cure of fragile X syndrome. These are flexible grants, but we expect that this program will be much more competitive than in the past, since fewer grants will be awarded. Successful applicants will be pursuing advanced translational, preclinical, and clinical research in fragile X.
FRAXA Research Foundation
10 Prince Place, Suite 203
Newburyport, MA 01950
American Society of Transplantation Transplant Research Institute Grant Program
Since 1995, the American Society of Transplantation (AST) has invested millions of dollars to spur innovative research that has dramatically enhanced the field of organ transplantation. In an effort to benefit a broader number of investigators in more creative ways, the AST established the Transplant Research Institute (TRI) for the purposes of expanding the scope, reach, and effectiveness of the AST's research program. Among its many goals, the TRI seeks to elicit novel research topics and collaborative research opportunities from its partners in both industry and academia that are critical to advancing the science and practice of transplantation.
For 2014, the AST TRI considers applications in the following grant categories:
Faculty Development Grants
Basic Science Faculty Development Grant
Clinical Science Faculty Development Grant
Basic Science Fellowship Grant
Clinical Science Fellowship Grant
Applications for TRI grants must be completed by 11:59 PM Pacific Time on Monday, December 16, 2013. The submission site will automatically close after the deadline. No applications or supplementary documents will be accepted after the submission deadline.
The funding of any grant and total number of grants awarded by the TRI is dependent upon budgetary constraints in a given year. Grants may be funded for a one- or two-year period.
Letters of recommendation with original signatures on institutional letterhead must be uploaded to the online application.
Applicants for Faculty Development Grants and sponsors of Fellowship Grants must be members of the AST. If an applicant or sponsor is not a member, he/she must submit a completed membership application prior to the submission deadline. It is expected that membership will be active before the grant recipient is selected. 2014 AST membership dues must be paid by January 1, 2014. Apply for membership here.
Recipients of an AST TRI Grant will be recognized at the World Transplant Congress, July 26-31, 2014, in San Francisco. Recipients are expected to attend the WTC and must register for the congress. Registration to the WTC is NOT included with your grant.
No indirect costs are permitted.
Grant funding is not transferable from one recipient to another.
Research should begin on July 1, 2014.
DISCLAIMER: The AST will not assume responsibility for any clinical study funded by the TRI. Such proposals must be IRB-approved. Any responsibility will be assumed by the PI and the funded institution.
Call for Applications: Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award
The purpose of this initiative is to speed the application of recent translational advances in gene therapy to clinical trials. The Foundation recognizes that there are many key areas worthy of support in the search for a cure for thalassemia with cell therapy and gene therapy. While several funding mechanisms are available for a range of studies on vector development, proof of concept studies in animal models, and transplantation, there remains a funding gap for launching human trials. Both phase I (safety) and phase II (efficacy) trials are eligible for support. Funding and candidate eligibility: Total funding of up to $60,000 per year will be available (including indirect costs of 8%). With satisfactory evidence of progress the grant may be renewed for a second year. The research may not be conducted at a for-profit laboratory. Because the purpose of the support is to facilitate launch of clinical trials, eligible studies proposed for this RFA must be accompanied by a realistic timeline of progress to human trials. The Foundation recognizes that this timeline can be long. Applicants should state explicitly the status of their proposed trials, for example whether the trial has been approved by the recombinant DNA Advisory Committee (RAC), or Food and Drug Administration (or equivalent processes at non-US sites), or whether review meetings at regulatory agencies have been scheduled. Awards will be announced in June 2014.
The completed application is due Monday February 3, 2014.
Call for Applications: Support for Ongoing Research in Thalassemia Grant
The Cooley’s Anemia Foundation invites national and international applications for 2014-2015 grants to support ongoing clinical research projects in Thalassemia. The goal of this initiative is to support investigators from all disciplines and backgrounds (MD, RN, PhD, MPH, MSW or other disciplines) with their ongoing clinical projects to address one or more of the following areas impacting patients with thalassemia: including but not limited to fertility, pregnancy and family planning; quality of life/psychosocial; burden of disease, cardiac issues and iron overload. The stipend will be $40,000 annually with possibility of one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. This level of funding would be appropriate for support of innovative small-scale pilot studies, observational trials, or ancillary support for ongoing interventional studies (for example support of a trainee joining an existing trial, or new biological endpoint analyses for an existing trial). In the case of ancillary studies, investigators should clearly document the support for the parent trial in their “other support” declarations. Junior and senior faculty are eligible; fellows and trainees are not eligible. Investigators must interact directly with patients or patient-related data. Awards will be announced in June 2014.
Request for Proposals: Clinical Studies on Benign Colorectal Disorders
Letter of Intent Deadline: August 1
Application Deadline: October 1
Through the RFP Program, the Research Foundation intends to encourage the conduct of well designed clinical trials leading to a definitive answer to a specific colorectal program. The goal of the Research Foundation’s RFP program is to foster outstanding research in specific areas of colorectal diseases or disorders leading to the improvement and management of common, yet understudied colorectal questions. Pilot studies or phase I, II, or III trials are all appropriate clinical study designs. A peer review mechanism with emphasis on scientific merit will be used to rate proposals.
• The proposed research must be hypothesis-driven and investigator-initiated
• The proposed research must be conducted within the United States or Canada
• ASCRS member must be the Principal Investigator or a Co-Principal Investigator
• The number of RFP grants and the level of funding will be made at the discretion of the Research Foundation Board of Trustees.
• The award may be funded in whole or in part.
• The award need not be given every year.
• Funds are for direct costs only and are intended to establish new studies.
Pediatric Infectious Diseases Society Fellowship Award
Completed applications for the Pediatric Infectious Diseases Society Fellowship Award must be received by March 7, 2014 for the award cycle that begins on July 1, 2014.
Goals: The goal of the Fellowship Awards is to help increase the pool of highly trained pediatric infectious disease clinical scientists and to stimulate scholarly basic and clinical research in the following areas pertinent to pediatrics: public health/epidemiology, hospital epidemiology, clinical trials of antimicrobials, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, research related to vaccine development, and other topics of relevance to pediatric infectious diseases.
NOTE: The Society encourages applications for clinically applied/translational research.
Eligibility: Candidates must possess a MD or MD/PhD and be at least a first-year fellow in a Pediatric Infectious Diseases program in North America at the time of application. The award will be given for two subsequent years of training, during which time the applicant is expected to devote the major portion (at least 75% of time) of those years conducting the proposed research project under the direct supervision of a mentor who must be a PIDS member in good standing for at least one year.
Support: The annual stipend will be $45,000 and will be given for two years, subject to review at the end of the first year. In the case of awards given to a candidate in the final year of fellowship, only one year of the award will be given to the recipient. The stipend is intended to provide salary and benefits for the fellow. It is not intended to provide resources for a division's research program, nor to pay indirect costs of the institution.
Application and Selection Process: Application materials must be received by 5:00 pm EST on Friday, March 7, 2014. Electronic submission is strongly preferred.
Society for Vascular Surgery Clinical Research Seed Grants
Application Deadline: January 17, 2014
In recognition of the importance of clinical investigation in vascular disease, the SVS Foundation announces the Clinical Research Seed Grant program.
Purpose: It is vitally important, both to patients and to the specialty, that vascular surgeons play prominent roles in both industry and investigator-initiated clinical trials. The Clinical Research Seed Grant program has the following goals:
Encourage the interest and development of clinical investigators among the SVS membership, particularly junior members or those with limited prior experience as Principal Investigators
Provide direct support for pilot clinical projects that have potential to develop into larger studies fundable by industry or governmental sources
Scope: Clinical research, preferably patient-oriented (research conducted with human subjects or on material of human origin such as tissues, specimens and cognitive phenomena for which an investigator directly interacts with human subjects). Applications addressing one of the SVS Clinical Research Priorities are particularly encouraged. Small-scale clinical trials and ancillary studies in the setting of existing clinical trials (industry or NIH-supported) will be accepted. Relevant examples include:
Ancillary studies coupled to existing clinical trials. A letter of support from the primary trial sponsor is required.
Pilot clinical trials of any type
Studies on the natural history of vascular disease, pathophysiology, or mechanisms underlying success or failure of vascular interventions
Application of quality-of-life, functional status, and resource utilization measures to assess the impact of vascular interventions
Development and validation of clinical risk-prediction models or diagnostic tools
Studies addressing the nature of disparities in care and outcomes
Funding: $15,000 will be awarded for direct costs for a one-year period. Costs for laboratory assays, imaging studies (as appropriate), data collection, and statistical support are allowable. Principal investigator salary, institutional overhead expenses, major equipment and travel expenses are not allowed.
Eligibility: The principal investigator for the Clinical Research Seed Grant must be 1) an SVS Active Member within the first 10 years of practice or 2) a fellowship-trained, board-eligible, vascular surgeon within the first 10 years of practice with a full-time faculty position with an SVS Active Member serving as mentor. The principal investigator may submit only one application for the Clinical Research Seed Grant. Residents and fellows are not eligible.
Application Process: The deadline for applications is January 17, 2014. An electronic copy of the complete application must be must be submitted to SVSFoundation@vascularsociety.org on January 17, 2014. You will receive an email confirmation when your application has been received. Applications include the following:
Clinical Research Seed Grant Face Page
Clinical Research Proposal:
1 page - Specific aims
6 pages - Significance, innovation and research strategy (includes tables, graphs, figures, diagrams, charts)
Biosketch of Principal Investigator and any Co-Investigators
If applicable, based on the eligibility requirements, the application should include letter(s) of support from the SVS Member serving as mentor and/or any significant collaborator or consultant on the project.
Review Process: Applications will be reviewed by the SVS Clinical Research and Comparative Effectiveness Committee. Decisions regarding the grants are sent to applicants in March.
Reporting Requirements: At the completion of the study, or by the end of the one-year award period, the awardee must submit a report to the SVS Clinical Research and Comparative Effectiveness Committee.
Contact: Sarah Murphy, Society for Vascular Surgery, (312) 334-2305, Email: email@example.com
Society for Surgery of the Alimentary Tract Career Development Award for Clinical/Outcomes/Education Research
Deadline: February 7, 2014
This award is to assist in the development of young faculty members engaged in clinical, outcomes, and/or educational research in digestive diseases.
The supported research can be focused on clinical, outcomes, and educational research in digestive diseases. This includes but is not limited to clinical trial development, patient-centered outcomes research, health services research, comparative effectiveness research, cost-effectiveness research, and educational research.
The award is restricted to surgeons who have completed formal clinical and research training in general surgery and are within 5 years of their first faculty appointment in a department of surgery at a medical school accredited by the Liaison Committee on Medical Education in the United States or by the Committee for Accreditation of Canadian Medical Schools in Canada, or the equivalent national accrediting body for applicants from other countries.
At least 25% of the applicant’s time should be dedicated to the research and training outlined in the research plan. The Head of the Department and/or Division of General Surgery must ensure the applicant has the required protected time for research.
The SSAT award of $20,000 per year for two years is a career development award and is meant to support young investigators who have not been funded by a National Institutes of Health R01 Award or equivalent. In addition, if an investigator has received a similar type of career development award from another organization such as the American College of Surgeons, American Surgical Association, etc., he/she will be ineligible for the SSAT Career Development Research Award. It is the applicant’s responsibility to notify the SSAT of potential funding conflicts.
The award may be used to support clinical trial infrastructure (research assistants, data analysts, etc.), purchase of large administrative datasets necessary for conducting research, education/formal training in clinical research/biostatistics, and principal investigator salary support to ensure protected research time. No portion of the award is to be used for institutional indirect costs.
The recipient will present a progress report the SSAT leadership at the Annual Meeting during and immediately following the award period.
It is expected that the recipient submit abstracts arising from his/her Career Development Award-funded research to the SSAT Annual Meeting for presentation consideration, as well as manuscripts to the Journal of Gastrointestinal Surgery, the official journal of the SSAT, for publication consideration.
Paffenbarger-Blair Fund for Epidemiological Research on Physical Activity
• Deadline: Jan 17, 2014
• Amount: $10,000.00 USD
• Number Given: 1
Dr. Ralph S. Paffenbarger, Jr., a co-recipient of the first Olympic Prize in Exercise Science and Sports Medicine, made an extraordinarily generous gift to the American College of Sports Medicine by donating his share of the award to the College's capital campaign with the monies added to the College's epidemiology endowment. The interest on this contribution makes this grant possible. The intent of this award is to encourage researchers early in their career to become involved with physical activity epidemiology. The applications may focus on observational studies of physical activity and health outcomes, or on randomized controlled trials that are clearly focused on physical activity and important public health issues. Applicants are expected to apply within two (2) years of receiving a postgraduate degree or completion of clinical training. The award will be in the amount of $10,000 for a one year period.
Applicants for student research grants must have graduate student status during the term of the grant to be considered for funding. Applicants must be current members of ACSM at the time of submitting an application to be funded. Grants are open to all ACSM members, including international members. However, the NASA initiative is open to U.S. residents only.
The deadline for the 2014 grant application was 5:00 PM ET on January 17, 2014.
You may contact the Research Administration and Programs Department regarding this grant at Tel: (317) 637-9200, ext. 143 or email questions to Jane Senior or Michael F. Dell.